Modulation of host immunity by HIV may be partly achieved through usurping host autonomic functions

Medical Hypotheses

Volumn 63, Issue 2, 2004, Pages 362-366

  Yun, A Joon ^a   Lee, Patrick Y ^a   Bazar, Kimberly A ^b  

^a STANFORD UNIVERSITY   (United States)

^b San Mateo County Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; STEROID;

ADAPTATION; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CACHEXIA; CARDIOMYOPATHY; CELL SURVIVAL; DISEASE COURSE; ENDOCRINE FUNCTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LIPODYSTROPHY; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SYMPATHETIC FUNCTION; SYNDROME; T LYMPHOCYTE; TH2 CELL; VAGUS NERVE; VIRUS IMMUNITY; VIRUS SURVIVAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 3242789484     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.02.027     Document Type: Article

References (80)

1. Selliah N., Shackelford J., Wang J.F., Traynor F., Yin J., Finkel T.H. T cell signaling and apoptosis in HIV disease. Immunol. Res. 27(2-3):2003;247-260
2. Haraguchi, Good R.A., James Y.M., Cianciolo G.J., Day N.K. Differential regulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to retroviral envelope protein. Proc. Natl. Acad. Sci. USA. 92:1995;3611-3615
3. Reinhart T.A. Chemokine induction by HIV-1: recruitment to the cause. Trends Immunol. 24(7):2003;351-353
4. Chanh T.C., Kennedy R.C., Kanda P. Synthetic peptides homologous to HIV-transmembrane glycoprotein suppress normal human lymphocyte blastogenic response. Cell Immunol. 111:1988;77-86
5. Weigent D.A., Hoeprich P.D., Bost K.L., Brunck T.K., Reiher W.E. III, Blalock J.E. The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that bind to the interleukin-2 receptor. Biochem. Biophys. Res. Commun. 139:1986;367-374
6. Raber J., Toggas S.M., Lee S., Bloom F.E., Epstein C.J., Mucke L. Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary- adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase. Virology. 226(2):1996;362-373
7. Mayne T.J., Vittinghoff E., Chesney M.A., Barrett D.C., Coates T.J. Depressive affect and survival among gay and bisexual men infected with HIV. Arch. Int. Med. 156:1996;2233-2238
8. Burack J.H., Barrett D.C., Stall R.D., Chesney M.A., Ekstrand M.L., Coates T.C. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 270:1993;2568-2573
9. Ironson G., Friedman A., Klimas N., et al. Distress, denial and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int. J. Behav. Med. 1:1994;90-105
10. Lyketsos C.G., Hoover D.R., Guccione M., et al. Depressive symptoms as predictors of medical outcomes in HIV infection. JAMA. 270:1993;2563-2567
11. Brown L.S. Jr., Singer F., Killian P. Endocrine complications of AIDS and drug addiction. Endocrinol. Metab. Clin. North. Am. 20:1991;655-673
12. Grinspoon S.K., Bilezikian J.P. HIV disease and the endocrine system. N. Engl. J. Med. 327:1992;1360-1365
13. Biglino A., Limone P., Forno B., et al. Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection. Eur. J. Endocrinol. 133:1995;173-179
14. Tauveron I., Thieblot P., Laurichesse H. The Cushing syndrome associated with AIDS. Ann. Int. Med. 120:1994;620-621
15. Mayo J., Collazos J., Martínez E., Ibarra S. Adrenal function in the human immunodeficiency virus - infected patient. Arch. Int. Med. 162(10):2002;1095-1098
16. Membreno L., Irony I., Dere W., Klein R., Biglieri E.G., Cobb E. Adrenocortical function in acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 65:1987;482-487
17. Villette J.M., Bourin P., Doinel C., et al. Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J. Clin. Endocrinol. Metab. 70:1990;572-577
18. Christeff N., Gherbi N., Mammes O., et al. Serum cortisol and DHEA concentrations. Psychoneuroendocrinology. 22(Suppl 1):1997;S11-S18
19. Clerici M., Trabattoni D., Piconi S., et al. A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus. Psychoneuroendocrinology. 22(Suppl 1):1997;S27-S31
20. Fujita Y., Murakami M., Ogawa Y., et al. Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin. Exp. Immunol. 128(1):2002;21-26
21. Nair M.P.N., Mahajan S., Hou J., Sweet A.M., Schwartz S.A. The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells. Cell. Mol. Biol. 46(7):2000;1227-1238
22. Ayyavoo V., Mahboubi A., Mahalingam S., et al. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med. 3(10):1997;1117-1123
23. Rogstad K.E., Shah R., Tesfaladet G., Abdullah M., Ahmed-Jushuf I. Cardiovascular autonomic neuropathy in HIV infected patients. Sex. Transm. Infect. 75(4):1999;264-267
24. Wulff E.A., Wang A.K., Simpson D.M. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs. 59:2000;1251-1260
25. Harmon W.G., Dadlani G.H., Fisher S.D., Lipshultz S.E. Myocardial and pericardial disease in HIV. Curr. Treat. Options. Cardiovasc. Med. 4(6):2002;497-509
26. Prendergast B.D. HIV and cardiovascular medicine. Heart. 89(7):2003;793-800
27. Parthenakis F.I., Patrianakos A., Prassopoulos V., et al. Relation of cardiac sympathetic innervation to proinflammatory cytokine levels in patients with heart failure secondary to idiopathic dilated cardiomyopathy. Am. J. Cardiol. 91(10):2003;1190-1194
28. Guirao X., Kumar A., Katz J., et al. Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation. Am. J. Physiol. 273:1997;E1203-E1208
29. Malfatto G., Branzi G., Gritti S., et al. Different baseline sympathovagal balance and cardiac autonomic responsiveness in ischemic and non-ischemic congestive heart failure. Eur. J. Heart Fail. 3(2):2001;197-202
30. Kocheril A.G., Bokhari S.A., Batsford W.P., Sinusas A.J. Long QTc and torsades de pointes in human immunodeficiency virus disease. Pacing. Clin. Electrophysiol. 20(11):1997;2810-2816
31. Batur M.K., Aksoyek S., Oto A., et al. Circadian variations of QTc dispersion: is it a clue to morning increase of sudden cardiac death? Clin. Cardiol. 22(2):1999;103-106
32. Schwartz P.J., Zaza A., Locati E., Moss A.J. Stress and sudden death. The case of the long QT syndrome. Circulation. 83(Suppl 4):1991;II71-II80
33. Gluck T., Degenhardt E., Scholmerich J., Lang B., Grossmann J., Straub R.H. Autonomic neuropathy in patients with HIV: course, impact of disease stage, and medication. Clin. Auton. Res. 10(1):2000;17-22
34. Barbaro G., Fisher S.D., Giancaspro G., Lipshultz S.E. HIV-associated cardiovascular complications: a new challenge for emergency physicians. Am. J. Emerg. Med. 19(7):2001;566-574
35. Brownley K.A., Milanovich J.R., Motivala S.J., et al. Autonomic and cardiovascular function in HIV spectrum disease: early indications of cardiac pathophysiology. Clin. Auton. Res. 11(5):2001;319-326
36. Nzuobontane D., Ngu B.K., Christopher K. Cardiovascular autonomic dysfunction in Africans infected with human immunodeficiency virus. J. R. Soc. Med. 95(9):2002;319-326
37. Plata-Salaman C.R. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition. 16(10):2000;1009-1912
38. Von Roenn J.H., Roth E.L., Craig R. HIV-related cachexia: potential mechanisms and treatment. Oncology. 49(Suppl 2):1992;50-54
39. Schols A.M. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur. Respir. J. Suppl. 46:2003;81s-86
40. Morley J.E. Pathophysiology of anorexia. Clin. Geriatr. Med. 18(4):2002;661-673
41. Rosenthal N., Musaro A. Gene therapy for cardiac cachexia? Int. J. Cardiol. 85(1):2002;185-191
42. Martignoni M.E., Kunze P., Friess H. Cancer cachexia. Mol. Cancer. 2(1):2003;36
43. Jones P.P., Christou D.D., Jordan J., Seals D.R. Baroreflex buffering is reduced with age in healthy men. Circulation. 107(13):2003;1770-1774
44. Heindl S., Lehnert M., Criee C.P., Hasenfuss G., Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. Am. J. Respir. Crit. Care. Med. 164(4):2001;597-601
45. Middlekauff H.R., Mark A.L. The treatment of heart failure: the role of neurohumoral activation. Int. Med. (37):1998;112-122
46. Francis G.S. Neurohumoral activation and progression of heart failure: hypothetical and clinical considerations. J. Cardiovasc. Pharmacol. 32:1998;S16-S21
47. Gould G.A., Ashworth M., Lewis G.T. Are cardiovascular reflexes more commonly impaired in patients with bronchial carcinoma? Thorax. 41(5):1986;372-375
48. Lavi S., Aharon-Peretz J., Haim N., Vlodavsky E., Jacob G. Unusual cause of partially reversible severe cardiovascular autonomic failure. Am. J. Med. Sci. 326(3):2003;159-163
49. Chang J.W., Yeh K.Y., Shen Y.C., et al. Production of multiple cytokines and induction of cachexia in athymic nude mice by a new anaplastic thyroid carcinoma cell line. J. Endocrinol. 179(3):2003;387-394
50. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52(4):2000;595-638
51. Kreier F., Fliers E., Voshol P.J., et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat - functional implications. J. Clin. Invest. 110(9):2002;1243-1250
52. Fliers E., Sauerwein H.P., Romijn J.A., et al. HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy. Lancet. 362(9397):2003;1758-1760
53. Neild P.J., Nijran K.S., Yazaki E. Delayed gastric emptying in human immunodeficiency virus infection: correlation with symptoms, autonomic function, and intestinal motility. Dig. Dis. Sci. 45(8):2000;1491-1499
54. Markarian Y., Wulff E.A., Simpson D.M. Peripheral neuropathy in HIV disease, AIDS. Clin. Care. 10(12):1998;89-91. 93, 98
55. Kumar M., Kumar A.M., Waldrop D., Antoni M.H., Eisdorfer C. HIV-1 infection and its impact on the HPA axis, cytokines, and cognition. Stress. 6(3):2003;167-172
56. Rogstad K.E., Shah R., Tesfaladet G., Abdullah M., Ahmed-Jushuf I. Cardiovascular autonomic neuropathy in HIV infected patients. Sex. Transm. Infect. 75(4):1999;264-267
57. Wulff E.A., Wang A.K., Simpson D.M. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs. 59:2000;1251-1260
58. Cole S.W., Naliboff B.D., Kemeny M.E., Griswold M.P., Fahey J.L., Zack J.A. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc. Natl. Acad. Sci. USA. 98(22):2001;12695-12700
59. Ottaway C.A., Husband A.J. The influence of neuroendocrine pathways on lymphocyte migration. Immunol. Today. 15(11):1994;511-517
60. Kammer G.M. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today. 9(7-8):1988;222-229
61. Ernst P.B., Song F., Klimpel G.R., et al. Regulation of the mucosal immune response. Am. J. Trop. Med. Hyg. 60(Suppl 4):1999;2-9
62. Felten S.Y., Felten D.L., Bellinger D.L., et al. Noradrenergic sympathetic innervation of lymphoid organs. Prog. Allergy. 43:1988;14-36
63. Weihe E., Nohr D., Michel S., et al. Molecular anatomy of the neuro-immune connection. Int. J. Neurosci. 59(1-3):1991;1-23
64. Pantaleo G., Graziosi C., Demarest J.F., et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 362(6418):1993;355-358
65. Elenkov I.J., Papanicolaou D.A., Wilder R.L., Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proc. Assoc. Am. Phys. 108(5):1996;374-381
66. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 97(3):1996;713-719
67. Suberville S., Bellocq A., Fouqueray B., Philippe C., Lantz O., Perez J., et al. Regulation of interleukin-10 production by beta-adrenergic agonists. Eur. J. Immunol. 26(11):1996;2601-2605
68. Panina-Bordignon P., Mazzeo D., Lucia P.D., et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100(6):1997;1513-1519
69. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52(4):2000;595-638
70. Lorton D., Lubahn C., Bellinger D.L. Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases. Curr. Drug Targets Inflamm. Allergy. 2(1):2003;1-30
71. Kedzierska K., Crowe S.M. Cytokines and HIV-1: interactions and clinical implications. Antivir. Chem. Chemother. 12(3):2001;133-150
72. Jones M.L., Young J.M., Huang Q.R., Puls R.L., Webber C.A., Benson E.M. Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor beta 2 upregulation. AIDS. Res. Hum. Retroviruses. 19(4):2003;283-292
73. Neild P.J., Amadi A., Ponikowski P., Coats A.J., Gazzard B.G. Cardiac autonomic dysfunction in AIDS is not secondary to heart failure. Int. J. Cardiol. 74(2-3):2000;133-137
74. Giordani L., Quaranta M.G., Malorni W., Boccanera M., Giacomini E., Viora M. N -acetylcysteine inhibits the induction of an antigen-specific antibody response down-regulating CD40 and CD27 co-stimulatory molecules Clin. Exp. Immunol. 129(2):2002;254-264
75. Bengtsson A., Lundberg M., Avila-Carino J., Jacobsson G., Holmgren A., Scheynius A. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells. Clin. Exp. Immunol. 123(3):2001;350-360
76. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8(3):2003;223-246
77. Barbaro G., Di Lorenzo G., Soldini M., et al. Vagal system impairment in human immunodeficiency virus-positive patients with chronic hepatitis C: does hepatic glutathione deficiency have a pathogenetic role? Scand. J. Gastroenterol. 32(12):1997;1261-1266
78. Roberts S.M., Skoulis N.P., James R.C. A centrally-mediated effect of morphine to diminish hepatocellular glutathione. Biochem. Pharmacol. 36(18):1987;3001-3005
79. Biernacki K., Prat A., Blain M., Antel J.P. Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J. Neuropathol. Exp. Neurol. 60(12):2001;1127-1136
80. Raber J., Toggas S.M., Lee S., Bloom F.E., Epstein C.J., Mucke L. Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary- adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase. Virology. 226(2):1996;362-373